Vico Therapeutics Alternatives & Competitors
12 companies similar to Vico Therapeutics — Our mission is simple… bring innovative RNA modulating therapies to patients wit...
Bloomsbury Genetic Therapies
Dedicated to delivering the promise of gene therapy
London, United Kingdom
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Bluejay Therapeutics
Developing innovative cures for infectious diseases with the first target indication of ch...
United States
Kyverna Therapeutics
Harnessing the power of cell therapy in autoimmune disease.
Emeryville, United States
Track all Vico Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Montara Therapeutics, Inc.
At Montara, we’re developing safer, more efficacious therapies to improve the lives of pat...
San Francisco, United Sta...
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
Ultragenyx
Going Beyond Every Day
Novato, United States
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
La Jolla, United States
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Alltrna
The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeu...
Cambridge, United States
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
About Vico Therapeutics
Our mission is simple… bring innovative RNA modulating therapies to patients with severe, genetic neurological diseases.
Development of Antisense Oligonucleotide Therapies, Clinical Trials for Genetic Disorders, Genetic Intervention Research
Patients with Rare Neurological Diseases, Caregivers, Advocacy Communities, Healthcare Providers specializing in Neurology
RNA Modulating Therapies, Genetic Neurological Diseases, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 1, Huntington’s Disease, Antisense Oligonucleotides, CNS Disorders, Rare Neurological Disorders, Ribonucleic Acid Therapies, Hereditary Ataxia, Neurodegenerative Disorders, Neurodevelopmental Disorders, VICOMER Platform, Rett Syndrome
B2B, B2B2B
Product Sales, Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Vico Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Vico Therapeutics on 10 Jun 2026. The 12 companies listed here were last checked between 4 Mar 2026 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.